Y YETNEWS Oct. 27, 2014 Udi Etsion An Israel icompany has developed and installed in Guinea special inflatable isolation tents to be used to house and isolate Ebola patients.
Special inflatable tent being used to fight Ebola
The inflatable tents have also been purchased for the treatment of Ebola patients by other countries on the continent, according to the Israeli company SYS Technologies, which specializes in the development of clean-air systems and mobile operating theaters. The company said the units can be constructed and shipped within two weels.
The units use a positive pressure technology to create an absolute clear and isolated environment and maintain the structure. The company has also developed an incubator-like stretcher for the safe transfer of patients to the isolation tents.
ASSOCIATED PRESS Oct. 28, 2014 GENEVA-- The Swiss agency that regulates new drugs said Tuesday it has approved an application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital.
In this picture provided by the World Health Organization, a package of vials of the first shipment of the experimental vaccine VSE-EBOV is opened at the Geneva Cantonal hospital on Wednesday, Oct. 22, 2014. The World Health Organization (WHO) welcomes the donation by the government of Canada of 800 vials of an experimental candidate vaccine, VSV-EBOV, against Ebola virus disease. Clinical safety trials with this experimental Ebola vaccine have already begun in healthy human volunteers in Mali, the United Kingdom and the United States after showing very promising results in animal research. . (AP Photo/WHO/Mathilde Missioneiro)
Swissmedic said the trial will be conducted among 120 volunteer participants with support from the U.N. World Health Organization. The experimental vaccine is to be initially administered on healthy volunteers who will be sent as medical staff to fight the Ebola epidemic in West Africa.
WASHINGTON--The Centers for Disease Control and Prevention leader Dr. Tom Frieden announced changes to the U.S. response to Ebola and the guidance federal agencies are giving to state and local governments.
The new protocol stops short of the mandatory 21-day quarantines that some states have begun requiring. Instead, Frieden said, it relies on individual assessment and close monitoring. He also detailed several categories of risk among both airline passengers and the medical volunteers who he said have been doing "heroic work" in West Africa.
"High risk" individuals, Frieden said, include those who have cared for an Ebola patient and were accidentally poked by a needle or lacked protective gear. Those people, Frieden said, should isolate themselves in their homes and avoid all forms of mass transit and large gatherings.
Hundreds of Americans have flown to Liberia in the past few days. Thousands more are on the way.
American troops setting up field hospital in Liberia --NYTimes
This Ebola corps is a collection of doctors, nurses, scientists, soldiers, aviators, technicians, mechanics and engineers. Many are volunteers with nonprofit organizations or the government, including uniformed doctors and nurses from the little-known U.S. Public Health Service. Most are military personnel, snapping a salute when are assigned to their mission — “Operation United Assistance.” It does not qualify for combat pay, only hardship-duty incentive pay, which is about $5 a day — before taxes....
With at least 4,500 people dead, public-health authorities in west Africa and worldwide are struggling to contain Ebola. Borders have been closed, air passengers screened, schools suspended. But a promising tool for epidemiologists lies unused: mobile cell phone data.
When people make mobile-phone calls, the network generates a call data record (CDR) containing such information as the phone numbers of the caller and receiver, the time of the call and the tower that handled it—which gives a rough indication of the device’s location. This information provides researchers with an insight into mobility patterns...
French scientists are developing a diagnostic tool that works similar to a home pregnancy test and can quickly identify the virus through a tiny fluid sample.
CEA's Ebola testing kit uses strips to rapidly identify the presence of the virus in fluid samples.--Courtesy of France's Atomic Energy Commission
France's Atomic Energy Commission (CEA) is teaming up with European pharma company Vedalab to roll out a user-friendly testing system than could diagnose Ebola in less than 15 minutes, the agency said in a statement. The kit, dubbed "Ebola eZYSCREEN," includes a hand-held device that reads small samples of blood, plasma or urine to detect the virus, and shows results in stripes through a window on the tool.
DOCTORS WITHOUT BORDERS/MEDECINS SANS FRONTIERE OCT. 23, 2014
Doctors without Borders (MSF) describes its specific guidelines and protocols for staff members returning from Ebola assignments. The guidlines were posted following the hospitalization of Dr. Craig Smith, one of its workers, in New York City yesterday.
WASHINGTON - The Obama administration is considering quarantining healthcare workers returning to the United States from the Ebola hot zone of West Africa, after a New York doctor who treated Ebola patients there tested positive for the virus.
Tom Skinner, a spokesman for the U.S. Centers for Disease Control and Prevention, told Reuters on Friday that quarantine is among a number of options being discussed by officials from across the administration.
Staff of the emergency medical services in France (SAMU) wear Ebola virus protection outfits during a press presentation at the Necker Hospital in Paris, October 24, 2014. Credit: Reuters/Philippe Wojazer
"There are a number of options being discussed pertaining to the monitoring and mobility of healthcare workers who are returning to the United States from affected countries," Skinner said.
GENEVA/LONDON, Oct 24 (Reuters) - Trials of Ebola vaccines could begin in West Africa in December, a month earlier than expected, and hundreds of thousands of doses should be available for use by the middle of next year, the World Health Organization said on Friday.
Vaccines are being developed and made ready in record time by drugmakers working with regulators, the U.N. health agency said, but questions remain about their safety and efficacy which can only be settled by full clinical trials.
"Vaccine is not a magic bullet, but when ready they may be a good part of the effort to turn the tide against the epidemic," senior WHO official Marie-Paule Kieny told a news briefing after a meeting in Geneva of industry executives, global health experts, drug regulators and funders.
Recent Comments